.svg)
The 340B Drug Pricing Program was created in 1992 to ensure that patients in need can receive prescription drugs. In the past thirty years, the program has evolved to include a wide variety of hospitals, clinics and health centers, impacting a predominantly low-income, uninsured or underinsured, disabled, rural or minority patient population. The 340B Drug Pricing Program is operated at no cost to taxpayers, and allows healthcare to be delivered to those who are most vulnerable.
Today, the 340B Drug Pricing Program faces pain points that stem from a lack of holistic infrastructure. The stakeholders in the pharmaceutical supply chain need a seamless process for collaboration, ultimately enabling patients to receive the treatment and access to affordable healthcare services they need.
What you’ll learn from the eBook, "What you need to know: The 340B Drug Pricing Program":
- Why the 340B Drug Pricing Program was created and how it has evolved
- How the 340B Drug Pricing Program works
- The systemic challenges that face all stakeholders in the 340B Drug Pricing Program today
Get up to speed on 340B: download the eBook, "What you need to know: The 340B Drug Pricing Program."
